Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach.
Saved in:
| Title: | Personalized tobramycin dosing in children with cystic fibrosis: an AUC |
|---|---|
| Authors: | Harwood KH; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Duffull S; Certara, Princeton, New Jersey, USA., Shanthikumar S; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.; Respiratory Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Lei A; Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Ranganathan S; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.; Respiratory Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Robinson P; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.; Respiratory Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Sandaradura I; The Children's Hospital at Westmead, Sydney, New South Wales, Australia.; University of Sydney, Sydney, New South Wales, Australia., Lai T; The Children's Hospital at Westmead, Sydney, New South Wales, Australia.; University of Sydney, Sydney, New South Wales, Australia., Gwee A; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of General Medicine, Royal Children's Hospital, Parkville, Victoria, Australia. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Sep 03; Vol. 69 (9), pp. e0027825. Date of Electronic Publication: 2025 Jul 23. |
| Publication Type: | Journal Article; Observational Study; Multicenter Study |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40698812 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Personalized tobramycin dosing in children with cystic fibrosis: an AUC<subscript>24</subscript>-guided approach. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Harwood+KH%22">Harwood KH</searchLink>; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Duffull+S%22">Duffull S</searchLink>; Certara, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Shanthikumar+S%22">Shanthikumar S</searchLink>; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.; Respiratory Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Lei+A%22">Lei A</searchLink>; Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Ranganathan+S%22">Ranganathan S</searchLink>; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.; Respiratory Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Robinson+P%22">Robinson P</searchLink>; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.; Respiratory Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Sandaradura+I%22">Sandaradura I</searchLink>; The Children's Hospital at Westmead, Sydney, New South Wales, Australia.; University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Lai+T%22">Lai T</searchLink>; The Children's Hospital at Westmead, Sydney, New South Wales, Australia.; University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Gwee+A%22">Gwee A</searchLink>; Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.; Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of General Medicine, Royal Children's Hospital, Parkville, Victoria, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2025 Sep 03; Vol. 69 (9), pp. e0027825. <i>Date of Electronic Publication: </i>2025 Jul 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40698812 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1128/aac.00278-25 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0027825 Titles: – TitleFull: Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Harwood KH – PersonEntity: Name: NameFull: Duffull S – PersonEntity: Name: NameFull: Shanthikumar S – PersonEntity: Name: NameFull: Lei A – PersonEntity: Name: NameFull: Ranganathan S – PersonEntity: Name: NameFull: Robinson P – PersonEntity: Name: NameFull: Sandaradura I – PersonEntity: Name: NameFull: Lai T – PersonEntity: Name: NameFull: Gwee A IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 09 Text: 2025 Sep 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1098-6596 Numbering: – Type: volume Value: 69 – Type: issue Value: 9 Titles: – TitleFull: Antimicrobial agents and chemotherapy Type: main |
| ResultId | 1 |